MENLO PARK, Calif., May 11, 2017 /PRNewswire/ -- BioPharmX Corporation (NYSE MKT: BPMX), a specialty pharmaceutical company developing products for the dermatology market, will host the State of Acne Symposium, an investor event being held in New York on June 1, 2017 from 8:00 – 10:30 a.m. EDT to review the detailed findings of its phase 2b acne study.
Should mark the 6/1/17 date for news.